|
Volumn 4, Issue 10, 2012, Pages 1029-1031
|
Back to the future: A new 'old' lead for tuberculosis
|
Author keywords
Antibiotic; InhA; Pyridomycin; Resistance; Tuberculosis
|
Indexed keywords
ETHIONAMIDE;
ISONIAZID;
KATG PROTEIN;
MYCOLIC ACID;
POLYKETIDE;
PROTEIN INHA;
PYRIDOMYCIN;
RIFAMPICIN;
STREPTOMYCIN;
TRICLOSAN;
UNCLASSIFIED DRUG;
ARTICLE;
BACTERIAL CELL WALL;
BACTERIOSTASIS;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TARGETING;
GENE;
HUMAN;
INHA GENE;
KATG GENE;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
TUBERCULOSIS;
ANTITUBERCULAR AGENTS;
BIOLOGICAL AGENTS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH;
|
EID: 84867055243
PISSN: 17574676
EISSN: 17574684
Source Type: Journal
DOI: 10.1002/emmm.201201811 Document Type: Article |
Times cited : (8)
|
References (10)
|